Health Boards
Tue-08-08-2023, 19:31 PM
(This post was last modified: Tue-08-08-2023, 19:36 PM by Kat. Edited 2 times in total.)
I just saw an ad for Sotyktu (deucravacitinib)
The FDA approved Sotyktu for use in the US at the end of 2022. Another oral medication. Their website says unsure if it can harm unborn baby and unsure if it can cause harm while breastfeeding. Also could cause liver problems and not for use with people who have rheumatoid arthritis.
First ad I've seen for it and I tend to look it up if it's new to me. It's always difficult to read the side effects and warnings.
(I saw where there was a post showing it was approved in the US but it had been removed but the one showing approval in England was still up. Not sure I'd be a fan of trying it but thought I'd put it out there anyway.)
The FDA approved Sotyktu for use in the US at the end of 2022. Another oral medication. Their website says unsure if it can harm unborn baby and unsure if it can cause harm while breastfeeding. Also could cause liver problems and not for use with people who have rheumatoid arthritis.
First ad I've seen for it and I tend to look it up if it's new to me. It's always difficult to read the side effects and warnings.
(I saw where there was a post showing it was approved in the US but it had been removed but the one showing approval in England was still up. Not sure I'd be a fan of trying it but thought I'd put it out there anyway.)